{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:56:55Z","timestamp":1768528615220,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s12072-019-09927-6","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T10:22:31Z","timestamp":1550744551000},"page":"173-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Sofosbuvir\u2013velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India"],"prefix":"10.1007","volume":"13","author":[{"given":"Ajit","family":"Sood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Duseja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayank","family":"Kabrawala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Amrose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhadadev","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiv Kumar","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Koshy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Hyland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Camus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa M.","family":"Stamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana M.","family":"Brainard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Mani","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhura","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shobna","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharmesh","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Saraswat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"9927_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jceh.2014.05.006","volume":"4","author":"P Puri","year":"2014","unstructured":"Puri P, Anand AC, Saraswat VA, et al. Consensus statement of HCV task force of the Indian National Association for study of the liver (INASL). Part I: status report of HCV infection in India. J Clin Exp Hepatol. 2014;4:106\u201316.","journal-title":"J Clin Exp Hepatol"},{"key":"9927_CR2","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","volume":"61","author":"E Gower","year":"2014","unstructured":"Gower E, Estes CC, Hindman S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus. J Hepatol. 2014;61:S45\u201357.","journal-title":"J Hepatol"},{"key":"9927_CR3","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1053\/jhep.2003.50157","volume":"37","author":"A Chowdhury","year":"2003","unstructured":"Chowdhury A, Santra A, Chaudhuri S, et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology. 2003;37:802\u20139.","journal-title":"Hepatology"},{"key":"9927_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12664-012-0251-8","volume":"31","author":"A Sood","year":"2012","unstructured":"Sood A, Sarin SK, Midha V, et al. Prevalence of hepatitis C virus in a selected geographical area of northern India: a population based survey. Indian J Gastroenterol. 2012;31:232\u20136.","journal-title":"Indian J Gastroenterol"},{"key":"9927_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4103\/1947-2714.103325","volume":"4","author":"S Sachdeva","year":"2012","unstructured":"Sachdeva S, Mehta B. Population-based hepatitis C survey in a rural block. N Am J Med Sci. 2012;4:591\u20132.","journal-title":"N Am J Med Sci"},{"key":"9927_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0377-1237(10)80093-0","volume":"66","author":"M Singh","year":"2010","unstructured":"Singh M, Kotwal A, Gupta RM, Adhya S, Chatterjee K, Jayaram J. Sero-epidemiological and behavioural survey of HIV, HBV and HCV amongst Indian armed forces trainees. Med J Armed Forces India. 2010;66:50\u20134.","journal-title":"Med J Armed Forces India"},{"key":"9927_CR7","first-page":"22","volume":"18","author":"MS Chadha","year":"1999","unstructured":"Chadha MS, Tungatkar SP, Arankalle VA. Insignificant prevalence of antibodies to hepatitis C in a rural area of western Maharashtra. Indian J Gastroenterol. 1999;18:22\u20133.","journal-title":"Indian J Gastroenterol"},{"key":"9927_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jceh.2013.10.002","volume":"3","author":"A Olithselvan","year":"2013","unstructured":"Olithselvan A, Rela M. Prevalence of hepatitis B and C in puducherry. J Clin Exp Hepatol. 2013;3:364\u20135.","journal-title":"J Clin Exp Hepatol"},{"key":"9927_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.meegid.2005.04.001","volume":"6","author":"MN Khaja","year":"2006","unstructured":"Khaja MN, Madhavi C, Thippavazzula R, et al. High prevalence of hepatitis C virus infection and genotype distribution among general population, blood donors and risk groups. Infect Genet Evol. 2006;6:198\u2013204.","journal-title":"Infect Genet Evol"},{"key":"9927_CR10","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1002\/hep.26905","volume":"59","author":"N Goossens","year":"2014","unstructured":"Goossens N, Negro F. Is genotype 3 of the hepatitis C virus the new villain? Hepatology. 2014;59:2403\u201312.","journal-title":"Hepatology"},{"key":"9927_CR11","doi-asserted-by":"publisher","first-page":"12101","DOI":"10.3748\/wjg.v21.i42.12101","volume":"21","author":"C Gondeau","year":"2015","unstructured":"Gondeau C, Pageaux GP, Larrey D. Hepatitis C virus infection: are there still specific problems with genotype 3? World J Gastroenterol. 2015;21:12101\u201313.","journal-title":"World J Gastroenterol"},{"key":"9927_CR12","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1186\/s12879-017-2820-z","volume":"17","author":"H Fathi","year":"2017","unstructured":"Fathi H, Clark A, Hill NR, Dusheiko G. Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic review. BMC Infect Dis. 2017;17:722.","journal-title":"BMC Infect Dis"},{"key":"9927_CR13","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","volume":"373","author":"JJ Feld","year":"2015","unstructured":"Feld JJ, Jacobson IM, H\u00e9zode C, et al. Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection. N Engl J Med. 2015;373:2599\u2013607.","journal-title":"N Engl J Med"},{"key":"9927_CR14","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1056\/NEJMoa1512612","volume":"373","author":"GR Foster","year":"2015","unstructured":"Foster GR, Afdhal N, Roberts SK, et al. Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection. N Engl J Med. 2015;373:2608\u201317.","journal-title":"N Engl J Med"},{"key":"9927_CR15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1440-1746.2009.05789.x","volume":"24","author":"M-L Yu","year":"2009","unstructured":"Yu M-L, Chuang W-L. Treatment of chronic hepatitis C in Asia: when East meets West. J Gastroenterol Hepatol. 2009;24:336\u201345.","journal-title":"J Gastroenterol Hepatol"},{"key":"9927_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/2168479013507272","volume":"48","author":"BL Weins","year":"2013","unstructured":"Weins BL, Lystig TC, Berry SM. Recent statistical contributions to medical device development. Therap Innovat Regul Sci. 2013;48:90\u20137.","journal-title":"Therap Innovat Regul Sci"},{"key":"9927_CR17","unstructured":"World Health Organization. Combating hepatitis B and C to reach elimination by 2030. May 2016. Available at: \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/206453\/1\/WHO_HIV_2016.04_eng.pdf?ua=1\n                    \n                  . Accessed 17 May 2018."}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-019-09927-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-019-09927-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-019-09927-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T19:17:39Z","timestamp":1582226259000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-019-09927-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["9927"],"URL":"https:\/\/doi.org\/10.1007\/s12072-019-09927-6","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,21]]},"assertion":[{"value":"24 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The following authors are employees of Gilead Sciences and may hold stock interest in the company: Robert H. Hyland, Sophia Lu, Gregory Camus, Luisa M. Stamm, Diana M. Brainard, and G. Mani Subramanian. All other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the review board or ethics committee of each institution prior to study initiation. The study was conducted in accordance with the International Conference on Harmonization Good Clinical Practice Guidelines and the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients provided written informed consent before undertaking any study-related procedures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}